No modern war has been fought on the territory of a country with nuclear power facilities.
Jeffrey Peppercorn was appointed the next editor-in-chief of JCO Oncology Practice, an American Society of Clinical Oncology journal. Peppercorn will begin serving as editor designee of JCO OP on March 1, and as editor-in-chief on Sept. 1.
Jhanelle Gray was named chair of the SWOG Cancer Research Network’s Lung Cancer Committee, effective April 1.
B.J. Rimel, associate professor of obstetrics and gynecology at Cedars-Sinai Cancer at the Cedars-Sinai Medical Center, has been named medical director for the Cancer Clinical Trials Office.
Marie Wood was named medical director of the Cancer Clinical Trials Office at The University of Colorado Cancer Center.
Joshua Eaves was named senior vice president of corporate development at Florida Cancer Specialists and Research Institute.
City of Hope’s Department of Stem Cell Biology and Regenerative Medicine received a $4.9 million grant from the California Institute for Regenerative Medicine to train scientists in basic stem cell research and its clinical translation.
A Harvard and Massachusetts General Hospital study found that an artificial intelligence model incorporating multiple methods of machine learning accurately detects thyroid cancer and predicts pathological and genomic outcomes through analysis of routine ultrasound images.
A phase II trial led by University of Michigan researchers found that PET scans obtained before and midway through treatment for p16-positive oropharynx cancer (OPC) can help determine whether a patient can receive a lower dose of radiation therapy in the second half of their treatment course without compromising cancer control.
A multi-institutional study demonstrated that a blood test to detect circulating tumor DNA can accurately predict recurrence of HPV-driven oropharyngeal cancer following treatment. Results also indicated that the biomarker test may detect recurrent disease earlier than imaging or other standard methods of post-treatment surveillance.